Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,168,489
-
Share change
-
-413,618
-
Total reported value
-
$38,502,000
-
Price per share
-
$7.45
-
Number of holders
-
23
-
Value change
-
-$1,720,592
-
Number of buys
-
11
-
Number of sells
-
11
Institutional Holders of AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) as of Q1 2017
As of 31 Mar 2017,
AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,168,489 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, JENNISON ASSOCIATES LLC, UNIVERSITY OF TEXAS INVESTMENT MANAGMENT CO, Rock Springs Capital Management LP, DAFNA Capital Management LLC, BAKER BROS. ADVISORS LP, Sio Capital Management, LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., and NUMERIC INVESTORS LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.